Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis.
Puéchal X, Iudici M, Perrodeau E, Bonnotte B, Lifermann F, Le Gallou T, Karras A, Blanchard-Delaunay C, Quéméneur T, Aouba A, Aumaître O, Cottin V, Hamidou M, Ruivard M, Cohen P, Mouthon L, Guillevin L, Ravaud P, Porcher R, Terrier B; French Vasculitis Study Group. Puéchal X, et al. Among authors: aumaitre o. JAMA Netw Open. 2022 Nov 1;5(11):e2243799. doi: 10.1001/jamanetworkopen.2022.43799. JAMA Netw Open. 2022. PMID: 36441554 Free PMC article.
Identification of EPX Variants in Human Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss).
David C, Hamel Y, Smahi A, Diot E, Benhamou Y, Girszyn N, Le Gallou T, Lifermann F, Godmer P, Maurier F, Cottin V, Grados A, Aumaitre O, Néel A, Pugnet G, Masson C, Puéchal X, Mouthon L, Guillevin L, Bienvenu T, Terrier B; French Vasculitis Study Group. David C, et al. Among authors: aumaitre o. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1960-1963.e3. doi: 10.1016/j.jaip.2023.02.019. Epub 2023 Mar 1. J Allergy Clin Immunol Pract. 2023. PMID: 36868475 No abstract available.
Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients.
Rohmer J, Nguyen Y, Trefond L, Agard C, Allain JS, Berezne A, Charles P, Cohen P, Gondran G, Groh M, Huscenot T, Lacout C, Lazaro E, London J, Maurier F, Mekinian A, Mesbah R, Nubourgh I, Perard L, Puéchal X, Pugnet G, Puyade M, Queyrel V, Roux A, Rouzaud D, Durel CA, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG). Rohmer J, et al. J Autoimmun. 2023 Sep;139:103093. doi: 10.1016/j.jaut.2023.103093. Epub 2023 Aug 1. J Autoimmun. 2023. PMID: 37536165
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials.
Delestre F, Charles P, Karras A, Pagnoux C, Néel A, Cohen P, Aumaître O, Faguer S, Gobert P, Maurier F, Samson M, Godmer P, Bonnotte B, Cottin V, Hanrotel-Saliou C, Le Gallou T, Carron PL, Desmurs-Clavel H, Direz G, Jourde-Chiche N, Lifermann F, Martin-Silva N, Pugnet G, Quéméneur T, Matignon M, Benhamou Y, Daugas E, Lazaro E, Limal N, Ducret M, Huart A, Viallard JF, Hachulla E, Perrodeau E, Puechal X, Guillevin L, Porcher R, Terrier B; French Vasculitis Study Group (FVSG). Delestre F, et al. Among authors: aumaitre o. Ann Rheum Dis. 2024 Jan 11;83(2):233-241. doi: 10.1136/ard-2023-224623. Ann Rheum Dis. 2024. PMID: 37918894
Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosus.
Thibault T, Rajillah A, Bourredjem A, Corneloup M, Maurier F, Wahl D, Muller G, Aumaitre O, Sève P, Blaison G, Besancenot JF, Martin T, Magy-Bertrand N, Samson M, Arnaud L, Amoura Z, Devilliers H; EQUAL Study Group. Thibault T, et al. Among authors: aumaitre o. Rheumatology (Oxford). 2024 May 2;63(5):1447-1455. doi: 10.1093/rheumatology/kead407. Rheumatology (Oxford). 2024. PMID: 37589711
The mediating effect of fatigue in impaired quality of life in systemic lupus erythematosus: mediation analysis of the French EQUAL cohort.
Thibault T, Bourredjem A, Maurier F, Wahl D, Muller G, Aumaitre O, Sève P, Blaison G, Pennaforte JL, Martin T, Magy-Bertrand N, Audia S, Arnaud L, Amoura Z, Devilliers H; EQUAL Study Group. Thibault T, et al. Among authors: aumaitre o. Rheumatology (Oxford). 2023 Sep 1;62(9):3051-3058. doi: 10.1093/rheumatology/kead020. Rheumatology (Oxford). 2023. PMID: 36655762
Efficacy of Mepolizumab for the Treatment of Eosinophilic Cystitis: A Report of 2 Cases.
Trefond L, Guy L, Darcha C, Gallon A, Thomas-Monier R, Berdugo K, Smets P, Olagne L, Stievenart J, Fayard D, Cathebras P, Aumaitre O, Boyer L, Andre M, Kahn JE. Trefond L, et al. Among authors: aumaitre o. J Investig Allergol Clin Immunol. 2024 Jun 17;34(3):202-204. doi: 10.18176/jiaci.0954. Epub 2023 Oct 18. J Investig Allergol Clin Immunol. 2024. PMID: 37850410 Free article. No abstract available.
Large-vessel involvement in ANCA-associated vasculitis: A multicenter case-control study.
Monghal V, Puéchal X, Smets P, Vandergheynst F, Michel M, Diot E, Ramdani Y, Moulinet T, Dhote R, Hautcoeur A, Lelubre C, Dominique S, Lebourg L, Melboucy S, Wauters N, Carlotti A, Cachin F, Ebbo M, Jourde-Chiche N, Iudici M, Aumaitre O, Andre M, Terrier B, Trefond L. Monghal V, et al. Among authors: aumaitre o. Semin Arthritis Rheum. 2024 Aug;67:152475. doi: 10.1016/j.semarthrit.2024.152475. Epub 2024 May 21. Semin Arthritis Rheum. 2024. PMID: 38810568
Risk factors for severe hearing loss in Susac syndrome: A national cohort study.
Peyre M, Mageau A, Henry Feugeas MC, Doan S, Halimi C, Klein I, Goulenok T, François C, Chauveheid MP, Papo T, Sacré K; French Susac Study Group. Peyre M, et al. Eur J Neurol. 2024 May;31(5):e16211. doi: 10.1111/ene.16211. Epub 2024 Jan 18. Eur J Neurol. 2024. PMID: 38235955 Free PMC article.
188 results